New research suggests GLP-1 medications like Ozempic and Mounjaro may double the risk of neovascular macular degeneration in diabetic patients, despite benefits for blood sugar control.

Wet macular degeneration, though less common, ... Key research findings. The investigation revealed striking differences in macular degeneration risk based on coffee type preference.

The new findings—identified using human plasma samples and mouse models of macular degeneration—suggest that increasing the amount apolipoprotein M (ApoM) in the blood may fix problems in ...

The findings of a new study may provide hope for patients with common eye diseases. | Credit: abbestock via Getty Images. Scientists have identified never-before-seen cells in the human eye that could ...

Here’s what you’ll learn when you read this story: Age-related macular degeneration (AMD) is the most common cause of blindness in people over the age of 50, and while there are treatments ...

"While the risk of developing macular degeneration while on a GLP-1 drug is low, patients should be aware of the possible eye side effects related to these types of medications," Reddy said.

Age-related macular degeneration (AMD) is a common eye disease — often seen in people 50 or older — that leads to vision loss due to damage to the macula, ... How Findings Changed Over Time.

Macular degeneration is the most frequent cause of irreversible vision loss in the developed world. It affects the macula -- the center of the light-sensitive retina at the back of the eye -- and ...

Nicks' mother suffered from dry macular degeneration. The Macular Disease Foundation Australia cites age as the strongest risk factor followed by genetic factors, which play a role in up to 70 ...